Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts

A Troeger1, L Glouchkova, G Escherich

  • 1Clinic for Pediatric-Oncology, -Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf, Germany. troeger@med.uni-duesseldorf.de

Klinische Padiatrie
|October 25, 2008
PubMed

Insights

Pediatric proB acute lymphoblastic leukemia (ALL) shows lower TNF receptor expression, impacting treatment response and relapse risk. This finding highlights potential new therapeutic targets for high-risk B-cell precursor ALL.

Area of Science:

  • Immunology
  • Pediatric Oncology
  • Molecular Biology

Background:

  • B cell precursor acute lymphoblastic leukemia (BCP-ALL) generally has a good prognosis, but a subset of pediatric patients with proB-ALL remains a therapeutic challenge.
  • These patients often experience relapse due to impaired treatment response and are classified into high-risk groups requiring intensified chemotherapy.
  • Long-term prognosis is also influenced by immunological control, with high expression of the TNF receptor CD40 potentially preventing late relapses in BCP-ALL.

Purpose of the Study:

  • To investigate the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in pediatric proB-ALL.
  • To compare the TNF receptor status on proB-ALL blasts with that of more mature preB- and c-ALL blasts.

Main Methods:

  • Flow cytometry (FACS) analysis was performed on samples from 5 patients with proB-ALL, 8 with preB-ALL, and 22 with c-ALL.
  • Baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules were determined.

Main Results:

  • Pediatric proB-ALL blasts exhibit significantly lower baseline expression of TNF receptor and costimulatory molecules compared to more mature precursor B-ALL blasts.
  • The capacity for CD40-induced modulation of these molecules is also diminished in proB-ALL blasts.

Conclusions:

  • The reduced expression and defective response to CD40 ligand stimulation in proB-ALL may reflect their immature phenotype.
  • This defect, along with increased chemoresistance, could contribute to the poorer prognosis in these patients by facilitating escape from apoptosis and immune surveillance.
Abstract

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...